JP Morgan Private Wealth Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14,586	Closed	-$274K	–	1948
2023 Q1	$274K	Sell	14,586 -836	-5%	-$13.7K	﹤0.01%	1718
2022 Q4	$212K	Buy	15,422 +1,401	+10%	+$21.5K	﹤0.01%	1802
2022 Q3	$268K	Sell	14,021 -17	-0.1%	-$310	﹤0.01%	1703
2022 Q2	$214K	Buy	14,038 +559	+4%	+$8.27K	﹤0.01%	1798
2022 Q1	$275K	Sell	13,479 -430	-3%	-$8.76K	﹤0.01%	1786
2021 Q4	$406K	Sell	13,909 -1,903	-12%	-$54.5K	﹤0.01%	1632
2021 Q3	$341K	Sell	15,812 -332	-2%	-$8.01K	﹤0.01%	1655
2021 Q2	$414K	Sell	16,144 -279	-2%	-$5.96K	﹤0.01%	1552
2021 Q1	$299K	Buy	+16,423	New	+$273K	﹤0.01%	1536

Other funds holding CDMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JP Morgan Private Wealth Advisors's CDMO Position: Q2 2023 in Review

JP Morgan Private Wealth Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2023, closing a stake of 14,586 shares — an estimated $274K sold.

JP Morgan Private Wealth Advisors first reported a position in CDMO in Q1 2021 and held it in 9 quarters. The position peaked at $414K in Q2 2021. 169 funds tracked by Wall St. Rank hold CDMO as of Q2 2023.

JP Morgan Private Wealth Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 14,586 Avid Bioservices, Inc. Common Stock shares in Q2 2023, an estimated $274K.
JP Morgan Private Wealth Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
JP Morgan Private Wealth Advisors's Avid Bioservices, Inc. Common Stock position peaked at $414K in Q2 2021.
169 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.